Evaluating colitis treatment efficacy and body composition changes using an IL-12/23 p40 neutralizing antibody, measured ...

Learn about the new guidelines released by the AGA for pharmacological management of moderate-to-severe ulcerative colitis.

The chronic condition can cause abdominal pain, diarrhea, bloody stools and fatigue. New research suggests it affects more ...

Crohn’s and colitis - During Crohn’s and Colitis Awareness Week, organisations from all over the globe come together to raise ...

What is Crohn’s disease? Start the day smarter. Get all the news you need in your inbox each morning. Crohn’s disease is a ...

Dr. Raymond Cross of Mercy Medical Center joins Jennifer Franciotti for a conversation about ulcerative colitis - how it ...

The number of UC patients in China is projected to double from 2019 to 2030 to approximately one million, highlighting the urgent need for novel treatments." said Rogers Yongqing Luo, Chief Executive ...

Inflammatory bowel disease (IBD) affects an estimated 1.6 million Americans. In fact, there are more than 70,000 new cases of ...

5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...

The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...